Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01030198 · ClinicalTrials.gov registry record · NA

Laser Treatment for Fresh Surgical Scars and Mature Scars

A NA study, sponsored by Cynosure.

Terminated
Registry status
NA
Development phase
7
Enrollment target

NCT01030198: Clinical Trial NA study, sponsored by Cynosure.

NCT01030198 is a NA study that was terminated before completion, run by Cynosure. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01030198, a NA study, was terminated before completion, sponsored by Cynosure.

TERMINATED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

The purpose of this study is to measure the effectiveness of the RevLite Laser in the treatment of both fresh surgical scars and mature/older scars.

Primary Outcome

The number of participants who experienced improvements in scar appearance, vascularity, height, pliability, pigmentation and any pre-existing pruritis will be counted.

Interventions

  • DEVICE RevLite (Laser Treatment)

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2010-01
Est. Completion 2010-12
Phase NA
Cynosure

49 total trials

Why NCT01030198 stopped before completion

NCT01030198 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which RevLite (Laser Treatment) is the first listed.

NCT01030198 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01030198 about?

NCT01030198 is a clinical study titled "Laser Treatment for Fresh Surgical Scars and Mature Scars". The purpose of this study is to measure the effectiveness of the RevLite Laser in the treatment of both fresh surgical scars and mature/older scars.

What is the current status of trial NCT01030198?

This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2010-01. Estimated completion is 2010-12.

What interventions are being tested in trial NCT01030198?

The interventions under investigation include: RevLite (Laser Treatment) (DEVICE).

Who is sponsoring clinical trial NCT01030198?

This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01030198's enrollment target sits among peer trials

7 1982nd of 2000 higher than 18 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01030198, the US trial registry maintained by the National Library of Medicine. NCT01030198 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.